Clinical trials of antitumoral drugs "Methotrexate-BMP"
The results of a clinical trial of the drug, «Methotrexate-BMP», tablets 5 mg (of RUE «Belmedpreparaty») obtained from a cohort of 47 patients diagnosed with inoperable squamous cell carcinoma of the head and neck. Based on the statistical analysis of clinical and laboratory parameters, the subjective assessment of patients and physicians opinions, «Methotrexate-BMP» has satisfactory tolerability, safety and effi cacy.